Literature DB >> 28320935

Triad of human cellular proteins, IRF2, FAM111A, and RFC3, restrict replication of orthopoxvirus SPI-1 host-range mutants.

Debasis Panda1, Daniel J Fernandez2, Madhu Lal2, Eugen Buehler2, Bernard Moss3.   

Abstract

Viruses and their hosts can reach balanced states of evolution ensuring mutual survival, which makes it difficult to appreciate the underlying dynamics. To uncover hidden interactions, virus mutants that have lost defense genes may be used. Deletion of the gene that encodes serine protease inhibitor 1 (SPI-1) of rabbitpox virus and vaccinia virus, two closely related orthopoxviruses, prevents their efficient replication in human cells, whereas certain other mammalian cells remain fully permissive. Our high-throughput genome-wide siRNA screen identified host factors that prevent reproduction and spread of the mutant viruses in human cells. More than 20,000 genes were interrogated with individual siRNAs and those that prominently increased replication of the SPI-1 deletion mutant were subjected to a secondary screen. The top hits based on the combined data-replication factor C3 (RFC3), FAM111A, and interferon regulatory factor 2 (IRF2)-were confirmed by custom assays. The siRNAs to RFC1, RFC2, RFC4, and RFC5 mRNAs also enhanced spread of the mutant virus, strengthening the biological significance of the RFC complex as a host restriction factor for poxviruses. Whereas association with proliferating cell nuclear antigen and participation in processive genome replication are common features of FAM111A and RFC, IRF2 is a transcriptional regulator. Microarray analysis, quantitative RT-PCR, and immunoblotting revealed that IRF2 regulated the basal level expression of FAM111A, suggesting that the enhancing effect of depleting IRF2 on replication of the SPI-1 mutant was indirect. Thus, the viral SPI-1 protein and the host IRF2, FAM111A, and RFC complex likely form an interaction network that influences the ability of poxviruses to replicate in human cells.

Entities:  

Keywords:  DNA replication factors; RNAi screen; host range; interferon regulatory factor; poxviruses

Mesh:

Substances:

Year:  2017        PMID: 28320935      PMCID: PMC5389286          DOI: 10.1073/pnas.1700678114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  An orthopoxvirus serpinlike gene controls the ability of infected cells to fuse.

Authors:  P C Turner; R W Moyer
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Common seed analysis to identify off-target effects in siRNA screens.

Authors:  Shane Marine; Amit Bahl; Marc Ferrer; Eugen Buehler
Journal:  J Biomol Screen       Date:  2011-11-15

3.  A recurrent de novo FAM111A mutation causes Kenny-Caffey syndrome type 2.

Authors:  Tsuyoshi Isojima; Koichiro Doi; Jun Mitsui; Yoichiro Oda; Etsuro Tokuhiro; Akihiro Yasoda; Tohru Yorifuji; Reiko Horikawa; Jun Yoshimura; Hiroyuki Ishiura; Shinichi Morishita; Shoji Tsuji; Sachiko Kitanaka
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

4.  Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever.

Authors:  S Kettle; A Alcamí; A Khanna; R Ehret; C Jassoy; G L Smith
Journal:  J Gen Virol       Date:  1997-03       Impact factor: 3.891

5.  Mother-to-daughter transmission of Kenny-Caffey syndrome associated with the recurrent, dominant FAM111A mutation p.Arg569His.

Authors:  S M Nikkel; A Ahmed; A Smith; J Marcadier; D E Bulman; K M Boycott
Journal:  Clin Genet       Date:  2013-10-23       Impact factor: 4.438

6.  Cell cycle regulation of histone H4 gene transcription requires the oncogenic factor IRF-2.

Authors:  P S Vaughan; C M van der Meijden; F Aziz; H Harada; T Taniguchi; A J van Wijnen; J L Stein; G S Stein
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

7.  Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.

Authors:  T Matsuyama; T Kimura; M Kitagawa; K Pfeffer; T Kawakami; N Watanabe; T M Kündig; R Amakawa; K Kishihara; A Wakeham
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

8.  A rabbitpox virus serpin gene controls host range by inhibiting apoptosis in restrictive cells.

Authors:  M A Brooks; A N Ali; P C Turner; R W Moyer
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

9.  Nascent chromatin capture proteomics determines chromatin dynamics during DNA replication and identifies unknown fork components.

Authors:  Constance Alabert; Jimi-Carlo Bukowski-Wills; Sung-Bau Lee; Georg Kustatscher; Kyosuke Nakamura; Flavia de Lima Alves; Patrice Menard; Jakob Mejlvang; Juri Rappsilber; Anja Groth
Journal:  Nat Cell Biol       Date:  2014-02-23       Impact factor: 28.824

Review 10.  Interferon-stimulated genes and their antiviral effector functions.

Authors:  John W Schoggins; Charles M Rice
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

View more
  15 in total

1.  Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells.

Authors:  Chen Peng; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-04       Impact factor: 11.205

2.  Vaccinia Virus C9 Ankyrin Repeat/F-Box Protein Is a Newly Identified Antagonist of the Type I Interferon-Induced Antiviral State.

Authors:  Ruikang Liu; Bernard Moss
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

3.  Identification of Vaccinia Virus Replisome and Transcriptome Proteins by Isolation of Proteins on Nascent DNA Coupled with Mass Spectrometry.

Authors:  Tatiana G Senkevich; George C Katsafanas; Andrea Weisberg; Lisa R Olano; Bernard Moss
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

4.  FAM111A is dispensable for electrolyte homeostasis in mice.

Authors:  Barnabas P Ilenwabor; Heidi Schigt; Andreas Kompatscher; Caro Bos; Malou Zuidscherwoude; Bram C J van der Eerden; Joost G J Hoenderop; Jeroen H F de Baaij
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

5.  Isolation and Characterization of vΔI3 Confirm that Vaccinia Virus SSB Plays an Essential Role in Viral Replication.

Authors:  Matthew D Greseth; Maciej W Czarnecki; Matthew S Bluma; Paula Traktman
Journal:  J Virol       Date:  2018-01-02       Impact factor: 6.549

6.  SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells.

Authors:  Ruikang Liu; Jorge D Mendez-Rios; Chen Peng; Wei Xiao; Andrea S Weisberg; Linda S Wyatt; Bernard Moss
Journal:  PLoS Pathog       Date:  2019-05-30       Impact factor: 6.823

7.  FAM111A protects replication forks from protein obstacles via its trypsin-like domain.

Authors:  Yusuke Kojima; Yuka Machida; Sowmiya Palani; Thomas R Caulfield; Evette S Radisky; Scott H Kaufmann; Yuichi J Machida
Journal:  Nat Commun       Date:  2020-03-12       Impact factor: 14.919

8.  FAM111A induces nuclear dysfunction in disease and viral restriction.

Authors:  Minghua Nie; Martina Oravcová; Yasaman Jami-Alahmadi; James A Wohlschlegel; Eros Lazzerini-Denchi; Michael N Boddy
Journal:  EMBO Rep       Date:  2020-12-28       Impact factor: 8.807

9.  Differential Regulation of Cellular FAM111B by Human Adenovirus C Type 5 E1 Oncogenes.

Authors:  Wing-Hang Ip; Britta Wilkens; Anastasia Solomatina; Judith Martin; Michael Melling; Paloma Hidalgo; Luca D Bertzbach; Thomas Speiseder; Thomas Dobner
Journal:  Viruses       Date:  2021-05-28       Impact factor: 5.048

10.  A vital gene for modified vaccinia virus Ankara replication in human cells.

Authors:  Gerd Sutter
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.